Pharmacological Reviews Get Tables of Contents delivered automatically
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/06/5804-742-759$7.00
Pharmacol Rev 58:742-759, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, D. D.
Right arrow Articles by Kliewer, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, D. D.
Right arrow Articles by Kliewer, S. A.

Article

International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor

David D. Moore, Shigeaki Kato, Wen Xie, David J. Mangelsdorf, Daniel R. Schmidt, Rui Xiao and Steven A. Kliewer

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (D.D.M., R.X.); The Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan (S.K.); Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania (W.X.); Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S.); and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas (D.J.M., D.R.S., S.A.K.)

Abstract
Introduction
Structures
    LXRalpha and beta
    FXRalpha
    VDR
    CAR
    PXR
Endogenous Ligands
    LXRalpha and beta
    FXRalpha
    VDR
    PXR and CAR
Synthetic Ligands and Selective Modulators
    LXRalpha and beta
    FXRalpha
    VDR
    PXR and CAR
Genetics
    LXRalpha and beta
    FXRalpha and beta
    VDR
    PXR and CAR
Abstract

The nuclear receptors of the NR1H and NR1I subgroups include the constitutive androstane receptor, pregnane X receptor, farnesoid X receptors, liver X receptors, and vitamin D receptor. The newly emerging functions of these related receptors are under the control of metabolic pathways, including metabolism of xenobiotics, bile acids, cholesterol, and calcium. This review summarizes results of structural, pharmacologic, and genetic studies of these receptors.


Address correspondence to: Dr. David D. Moore, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030. E-mail: moore{at}bcm.tmc.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
N. Hariparsad, B. A. Carr, R. Evers, and X. Chu
Comparison of Immortalized Fa2N-4 Cells and Human Hepatocytes as in Vitro Models for Cytochrome P450 Induction
Drug Metab. Dispos., June 1, 2008; 36(6): 1046 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Guo, J. Sarkar, K. Suino-Powell, Y. Xu, K. Matsumoto, Y. Jia, S. Yu, S. Khare, K. Haldar, M. S. Rao, et al.
Induction of Nuclear Translocation of Constitutive Androstane Receptor by Peroxisome Proliferator-activated Receptor {alpha} Synthetic Ligands in Mouse Liver
J. Biol. Chem., December 14, 2007; 282(50): 36766 - 36776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Das, M. Schapira, M. Tomic-Canic, R. Goyanka, T. Cardozo, and H. H. Samuels
Farnesyl Pyrophosphate Is a Novel Transcriptional Activator for a Subset of Nuclear Hormone Receptors
Mol. Endocrinol., November 1, 2007; 21(11): 2672 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. N. MARGOLIS
Nuclear Receptors and Bone
Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 327 - 334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics